Specific molecular targeting of renal injury in obstructive nephropathy.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 16988728.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Progression of most renal disease involves tubulointerstitial injury, characterized by tubular atrophy, inflammatory cell infiltration, and interstitial fibrosis. Transforming growth factor-beta1 is central in this process. As reported by Moon et al., molecular targeting of the transforming growth factor-beta1 signaling pathway can markedly suppress renal injury resulting from unilateral ureteral obstruction, an established model of obstructive nephropathy. Specific kinase inhibitors are promising therapeutic agents to slow or attenuate progressive renal fibrosis.
Medical subject headings
- Activin Receptors
- Kidney
- Kidney Diseases
- Transforming Growth Factor beta1
- Ureteral Obstruction